Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 130 | 159 | 37 | 0 | 0 |
| Gross Profit | 130 | 159 | 37 | N/A | N/A |
| Operating Expenses | 1,815 | 1,580 | 633 | 532 | 143 |
| Operating Income | -1,686 | -1,421 | -596 | -532 | -143 |
| Other Income | 427 | -232 | -42 | 356 | -63 |
| Pre-tax Income | -1,259 | -1,652 | -638 | -176 | -205 |
| Income Tax | N/A | N/A | N/A | N/A | 1 |
| Net Income Continuous | -1,259 | -1,400 | -638 | -176 | -206 |
| Net Income Discontinuous | -303 | N/A | N/A | N/A | N/A |
| Net Income | $-1,562 | $-1,508 | $-638 | $-176 | $-206 |
| EPS Basic Total Ops | -1.10 | -1.10 | -0.50 | -0.30 | -0.40 |
| EPS Basic Continuous Ops | -0.90 | -1.11 | -0.47 | -0.26 | -0.36 |
| EPS Basic Discontinuous Ops | -0.20 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.10 | -1.40 | -0.50 | N/A | -0.40 |
| EPS Diluted Continuous Ops | -0.90 | -1.37 | -0.47 | N/A | -0.36 |
| EPS Diluted Discontinuous Ops | -0.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,579 | $-1,348 | $-594 | $-531 | $-142 |